Management of Adult Jehovah's Witness Patients with Acute Bleeding

American Journal of Medicine

Volumn 122, Issue 12, 2009, Pages 1071-1076

  Berend, Kenrick ^a   Levi, Marcel ^b  

^a St Elisabeth Hospital Willemstad   (Netherlands Antilles)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute bleeding; Jehovah's Witnesses; Review

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYANOCOBALAMIN; DESMOPRESSIN; DOPAMINE; FERRIC CARBOXYMALTOSE; FERRIC GLUCONATE; FERRIC HYDROXIDE SUCROSE; FIBRIN GLUE; FOLIC ACID; HEMOGLOBIN; HEMOSTATIC AGENT; IRON; IRON DEXTRAN; NORADRENALIN; OCTREOTIDE; OXYGEN; PHYTOMENADIONE; PROGESTERONE; PROTHROMBIN COMPLEX; PROTON PUMP INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT ERYTHROPOIETIN; SOMATOSTATIN; TRANEXAMIC ACID; UNCLASSIFIED DRUG; VITAMIN K GROUP;

ANAPHYLAXIS; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; BLUNT TRAUMA; BRAIN HEMORRHAGE; CAUTERIZATION; DISEASE SEVERITY; DRUG MEGADOSE; EPISTAXIS; ESOPHAGUS VARICES BLEEDING; GASTROINTESTINAL HEMORRHAGE; GAUZE DRESSING; HEMOGLOBIN SYNTHESIS; HEMOPHILIA A; HEMOSTASIS; HUMAN; HYPOTENSION; HYPOVOLEMIC SHOCK; INFORMED CONSENT; INJECTION PAIN; JEHOVAH'S WITNESS; LEGAL ASPECT; MEDICAL ETHICS; MUSCLE BLEEDING; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; REVIEW; SUTURING METHOD; THROMBOCYTE ANOMALY; THROMBOSIS; TREATMENT INDICATION; TREATMENT REFUSAL; URINARY TRACT HEMORRHAGE; VON WILLEBRAND DISEASE;

ACUTE DISEASE; ADULT; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD TRANSFUSION; EMERGENCIES; ERYTHROPOIETIN, RECOMBINANT; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HUMANS; INFORMED CONSENT; JEHOVAH'S WITNESSES; PHLEBOTOMY; SHOCK; TREATMENT REFUSAL; UNCONSCIOUSNESS; VITAMIN K;

EID: 72149089336     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.06.028     Document Type: Review

References (46)

1. Muramoto O. Bioethical aspects of the recent changes in the policy of refusal of blood by Jehovah's Witnesses. BMJ 322 (2001) 37-39
2. The Watchtower (1989 Mar 1) 6-7
3. Chua R., and Tham K.F. Will "no blood" kill Jehovah Witnesses?. Singapore Med J 47 (2006) 994-1002
4. Harrington C. Father shunned by family for defying faith to save child. Canadian Press (Mar 11, 2002)
5. Wilson P. Jehovah's Witness children: when religion and the law collide. Paediatr Nurs 17 (2005) 34-37
6. 2 × kg(-1) × min(-1). Anesthesiology 92 (2000) 407-413
7. Weiskopf R.B., Kramer J.H., Viele M., et al. Acute severe isovolemic anemia impairs cognitive function and memory in humans. Anesthesiology 92 (2000) 1646-1652
8. Ferzli G.S., Hurwitz J.B., Fiorillo M.A., et al. Laparoscopic splenectomy in a Jehovah's Witness with profound anemia. Surg Endosc 11 (1997) 850-851
9. Ng K.O., Chow L.H., Wang C.C., et al. Successful management of massive blood loss to extremely low hemoglobin in an elderly woman receiving spinal surgery. Acta Anaesthesiol Sin 38 (2000) 89-92
10. Meier D.E., Back A.L., and Morrison R.S. The inner life of physicians and care of the seriously ill. JAMA 286 (2001) 3007-3014
11. Smith S. The role of the court in ethical decision making. Clin Med 1 (2001) 371-373
12. Marsh J.C., and Bevan D.H. Haematological care of the Jehovah's Witness patient. Br J Haematol 119 (2002) 25-37
13. Jehovah's Witnesses and Blood: A Physician's Guide to Saving Lives and Limiting Personal Liability. www.ajwrb.org/physicians/download.shtml Accessed December 6, 2008
14. Bodnaruk Z.M., Wong C.J., and Thomas M.J. Meeting the clinical challenge of care for Jehovah's Witnesses. Transfus Med Rev 18 (2004) 105-116
15. Vincent J.L. Transfusion in the exsanguinating Jehovah's Witness patient-the attitude of intensive-care doctors. Eur J Anaesthesiol 8 (1991) 297-300
16. De Jonge E., and Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med 29 (2001) 1261-1267
17. Trouwborst A., Hagenouw R.R., Jeekel J., and Ong G.L. Hypervolaemic haemodilution in an anaemic Jehovah's Witness. Br J Anaesth 64 (1990) 646-648
18. Palmer K., Nairn M., and Guideline Development Group. Management of acute gastrointestinal blood loss: summary of SIGN guidelines. BMJ 337 (2008) a1832
19. Sharara A.I., and Rockey D.C. Gastroesophageal variceal hemorrhage. N Engl J Med 345 (2001) 669-681
20. Crew J.P., Jephcott C.R., and Reynard J.M. Radiation-induced haemorrhagic cystitis. Eur Urol 40 (2001) 111-123
21. Remonda L., Schroth G., Caversaccio M., et al. Endovascular treatment of acute and subacute hemorrhage in the head and neck. Arch Otolaryngol Head Neck Surg 126 (2000) 1255-1262
22. Munro M.G., Mainor N., Basu R., et al. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: A randomized controlled trial. Obstet Gynecol 108 (2006) 924-929
23. Levi M. Emergency reversal of antithrombotic treatment. Intern Emerg Med 4 (2009) 137-145
24. Levi M., and Opal S.M. Coagulation abnormalities in critically ill patients. Crit Care 10 (2006) 222
25. Leissinger C.A., Blatt P.M., Hoots W.K., and Ewenstein B. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literture. Am J Hematol 83 (2008) 137-143
26. DeZee K.J., Shimeall W.T., Douglas K.M., et al. Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis. Arch Intern Med 166 (2006) 391
27. Fiore L.D., Scola M.A., Cantillon C.E., and Brophy M.T. Anaphylactoid reactions to vitamin K. J Thromb Thrombolysis 11 (2001) 175-183
28. Mannucci P.M., and Levi M. Prevention and treatment of major blood loss. N Engl J Med 31 (2007) 2301-2311
29. Levi M., Peters M., and Buller H.R. Efficacy and safety of recombinant factor VIIa for the treatment of severe bleeding: a systematic review. Crit Care Med 33 (2005) 883-890
30. Goldberg R., and Drummond K.J. Recombinant activated factor VII for a warfarinised Jehovah's Witness with an acute subdural haematoma. J Clin Neurosci 15 (2008) 1164-1166
31. Boffard K.D., Riou B., Warren B., et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59 (2005) 8-15
32. Mayer S.A., Brun N.C., Begtrup K., et al., FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 358 (2008) 2127-2137
33. Franchini M. The use of desmopressin as a hemostatic agent: a concise review. Am J Hematol 82 (2007) 731-735
34. Silverstein S.B., and Rodgers G.M. Parenteral iron therapy options. Am J Hematol 76 (2004) 74-78
35. Miller H.J., Hu J., Valentine J.K., and Gable P.S. Efficacy and tolerability of intravenous ferric gluconate in the treatment of iron deficiency anemia in patients without kidney disease. Arch Intern Med 167 (2007) 1327-1328
36. Van Iperen C.E., Gaillard C.A., Kraaijenhagen R.J., Braam B.G., Marx J.J., and van de Wiel A. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 28 (2000) 2773-2778
37. Gannon C.J., and Napolitano L.M. Severe anemia after gastrointestinal hemorrhage in a Jehovah's Witness: new treatment strategies. Crit Care Med 30 (2002) 1893-1895
38. Corwin H.L., Gettinger A., Rodriguez R.M., et al. Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial. Crit Care Med 27 (1999) 2346-2350
39. De Andrade J.R., Jove M., Landon G., et al. Baseline hemoglobin as a predictor of risk of transfusion and response to epoietin alfa in orthopedic surgery patients. Am J Orthop 25 (1996) 533-542
40. Remmers P.A., and Speer A.J. Clinical strategies in the medical care of Jehovah's Witnesses. Am J Med 119 (2006) 1013-1018
41. Ball A.M., and Winstead P.S. Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. Pharmacotherapy 28 (2008) 1383-1390
42. Gannon C.J., and Napolitano L.M. Severe anemia after gastrointestinal hemorrhage in a Jehovah's Witness: new treatment strategies. Crit Care Med 30 (2002) 1893-1895
43. Eyster E., and Bernene J. Nosocomial anemia. JAMA 223 (1973) 73-74
44. Smoller B.R., and Kruskall M.S. Phlebotomy for diagnostic laboratory tests in adults. N Engl J Med 314 (1986) 1233-1235
45. Levy J.H. The use of haemoglobin glutamer-250 (HBOC-201) as an oxygen bridge in patients with acute anaemia associated with surgical blood loss. Expert Opin Biol Ther 3 (2003) 509-517
46. Natanson C., Kern S.J., Lurie P., et al. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 299 (2008) 2304-2312